Whole exome sequencing (WES) has made the identification of causative SNVs/InDels associated with rare Mendelian conditions increasingly accessible. Incorporation of softwares allowing CNVs detection into the WES bioinformatics pipelines may increase the diagnostic yield.
| BACKGROUND
The identification of the causative DNA lesion is central to genomic medicine, although in most cases it is complicated by genetic heterogeneity, variable expressivity, and incomplete penetrance. The emerging literature on digenic inheritance 1,2 makes further challenging the identification of disease-causing genes and variants.
The expectations created by precision medicine and the immense funding dedicated to it worldwide have made urgent to get the molecular diagnosis in genetic diseases, in order to entertain the more appropriate therapeutic strategy for the patient, and any possible prevention in relatives and fetuses at risk.
Since the last 10 years, genomic arrays have represented the first-tier analysis in different clinical conditions, both sporadic and familial, [3] [4] [5] allowing to detect Copy Number Variations (CNVs) or, when SNP-specific probes are included in the platform, also regions of copy-neutral loss of heterozygosity (cnLOH). The latter may be responsible for a clinical condition if the affected region contains either imprinted genes or at least one disease-variant, heterozygous in 1 parent and reduced to homozygosity. 6, 7 More recently, Next Generation Sequencing (NGS) technologies have made increasingly accessible the identification of both single nucleotide variants (SNVs) and small insertions/deletions (InDels), largely overcoming the problem of genetic and phenotypic heterogeneity. 8 However, among the 141 000 genomic lesions reported in the Human Gene Mutation Database (HGMD), 10% consists of the total or partial deletion or duplication of the disease-associated genes. 9 Moreover, the association of a CNV with a loss of function or hypomorphic SNV in the other allele accounts for a proportion of autosomalrecessive diseases. 10, 11 Although whole-genome sequencing (WGS) is able to provide information regarding point mutations and structural abnormalities, the cost and the objective difficulty in interpreting the numerous variants impair its application on a routine basis.
In contrast, the easier handling of the whole exome sequencing (WES) data made it part of the diagnostic routine in many genetics laboratories. Incorporation of the CNVs detection in the WES bioinformatics pipelines is more and more common, although no standard protocols are so far available, and the accuracy of the CNVs call is influenced by several factors, including the panel design, the sequencing technology, the reads length, and the local sequence context. [12] [13] [14] Obviously, CNVs in non-coding regions are totally missed by WES, in spite of their possible role in the regulation of flanking genes expression. 15 Therefore, in a number of laboratories an initial investigation by genomic arrays is followed, in the negative cases, by WES analysis or sequencing of specific panels of genes fitting with the proband phenotype.
Thus, achieving a molecular diagnosis often involves multiple different investigations that are planned case-by-case based on the more probable hypothesis. The availability of a single test, able to identify at the same time most of the molecular causes of the genetic disorders, would be of great advantage, allowing to reduce the number of tests, the final cost, and the reporting time-frame.
We conducted a validation study on a cohort of cases with previously identified genomic alterations, which was re-analyzed by using a commercial target-enrichment kit, allowing the concurrent detection of CNVs, SNVs/InDels and LOH events. In most of these cases, several tests had been applied before to reach a diagnosis, whereas by using this approach we would have been able to highlight the molecular etiology of the disease by a single experiment.
| MATERIALS AND METHODS

| Clinical details and previous molecular investigations
The details for the reported cases are summarized in Table 1 . Cases 1, 11 and 12 were prenatally diagnosed because of ultrasound abnormalities. Cases 3, 4-6, 11, 13, 15, and 17 have been previously described. [16] [17] [18] [19] [20] [21] [22] Relevant data are available at DECIPHER (https:// decipher.sanger.ac.uk/index, see Table 1 ).
| Case 1
A 41-year-old woman was referred to genetic investigations at 
| Case 2
The patient, a 2-year-old male, was suspected to be affected by the 
| Case 7
The newborn male was born spontaneously at 36 + 4 weeks of gestation (Apgar 8/1 0 and 8/5 0 ). Birth weight and length were 3330 g (25-50 centile) and 49.5 cm (25 centile), respectively and head circumference was 34.5 cm (50 centile). Bilateral arthrogryposis, involving both knees and elbows, and right cryptorchidism were noticed.
Kidney and brain echography were normal, whereas echocardiography showed patent foramen ovale.
Two angiomas were noticed, a frontal one extended up to the eyelids, and a nuchal one. Karyotype analysis on peripheral blood lymphocytes, showed the presence in all the metaphases of a SMC (supernumerary marker chromosome) that was classified, after array-CGH (180 K, Figure 1 ) and FISH analyses, as a neocentric inv dup (17) (p13. 
| Case 8
This 5 
| Case 9
The patient was ascertained at the age of 12 years because of severe scoliosis. Her growth parameters have always been below the third centile, and facial and body asymmetry with right hemibody hyperplasia were evident. She showed facial dysmorphisms, renal fusion with discoid kidney and ostium secundum atrial septal defect, surgically treated at 7 years of age. She also showed hyper-and hypopigmented skin lines.
Cytogenetic investigations were performed on both peripheral blood lymphocytes and cultured skin fibroblasts. The blood karyotype resulted to be 46,XX, whereas a trisomy 22 was found in two-third of the fibroblast metaphases: 46,XX [15] /47,XX + 22 [31] . Array-CGH (180 K) from skin fibroblasts showed the trisomy 22 with an average log 2 ratio of +0.48 ( Figure S1 ).
| Case 10
A 7-year-old boy was referred to our unit to re-examine a rearrangement detected at prenatal cytogenetic investigations. He presented with normal auxological parameters but a mild language delay requiring the support of a speech therapist. 
| Case 13
The 
| Case 14
The patient was born at 37 weeks of gestation from a pregnancy characterized by polyhydramnios. Immediately after birth, he received endotracheal intubation, manual ventilation and oxygen therapy with recovery of the general conditions. He presented with short stature, axial hypotonia, vomiting and polyuria. Kidney echography was normal.
A tentative diagnosis of Bartter syndrome was made. Genetic analysis identified compound heterozygosity for a missense c.446T>A mutation in CLCNKB and a deletion encompassing CLCNKA 
| Case 16
This child, born from consanguineous parents, was referred because of retinitis pigmentosa (RP, MIM: #268000) at the age of 4 years. b The aberration was not detected by using standard parameters, but identified by a dedicated analysis. 
| Conventional and molecular cytogenetic analyses
We set up PHA-stimulated lymphocytes cultures of cases 3, 6-10, and After hybridization and indexing, 8-samples pools were prepared and sequenced by using a rapid run 2 × 100 bp paired-end protocol, on the HiSeq2500 (Illumina, San Diego, California).
| Bioinformatics analysis and variants interpretation
We used an in-house pipeline that implemented for CNVs analysis by EXCAVATOR. 25 Accordingly, reads were aligned to the human genome reference (GRCh37/hg19). Data processing and variant annotation was performed as previously reported. 26 
| RESULTS AND DISCUSSION
The number of sequencing reads passing mapping quality filters in BAM files ranged from 80 to 110 million for all samples. Percentage of duplicate reads was from 6% to 9%. On-target reads Table 1 .
| Disease-associated CNVs
In samples 1 to 4, 6 and 7, we correctly detected all the CNVs previously identified by array-CGH. These included large rearrangements visible by conventional cytogenetics and SMCs ( Figure 1, cases 1, 6 and 7), and microdeletions/duplications ranging from 260 kb (case 4) to 1.4 Mb (case 2) ( Figure S2A ). Among them, the duplication of the non-coding RevSex region located upstream of the SOX9 gene, responsible for testis development in 46,XX individuals (case 3), 16 would have been missed by conventional WES approach as well as by low resolution array platforms.
In cases 6 and 7, the tetrasomic regions (copy number >3) due to the presence of inverted duplicated SMCs 29 were correctly classified by our approach. 
| Critical cases
The deletion in cases 5 and 16 was not detected by EXCAVATOR under standard parameters but we were anyway able to pick-up and 
| CONCLUSIONS
The purpose of our study was to investigate the ability of a single test, based on target enrichment and NGS, to identify different types of genomic lesions, including SNVs/InDels, LOH, and large deletions/ duplications not necessarily containing protein-coding genes.
Different approaches for CNVs detection from WES data have already been reported, demonstrating an increased diagnostic yield up to 6% (an average of 2%), that can be obtained without additional direct laboratory costs, but by optimization of the data analysis. 35 In our cohort, 3 cases (cases 1, 11 and 12) were fetuses with severe ultrasound abnormalities requiring invasive sampling, cytogenetic and molecular investigations. Moreover, the condition affecting other 7 cases might have been suspected prenatally (cases 2, 3, 7, 9, 13-15). In all these cases a targeted sequencing approach integrating SNVs/InDels, CNVs and LOH analysis in a single NGS experiment, would have had the undoubted advantage of a rapid diagnosis. These findings further strengthen that our approach is particularly useful in a prenatal setting, where the time-frame for a genetic diagnosis is short.
In our cohort, the turnaround time from DNA extraction to data analysis and reporting was on average 15 days that could be possibly reduced by the novel approaches for faster library preparation. Since the platform we used contains only genes whose variants associate with known pathological conditions, the need for extended segregation studies in the family or in other families with similar pathologies is negligible. This fact dramatically shortens investigation times over the entire exome platforms, especially if parental and sibship DNA is already available for Sanger analysis.
Genomic arrays are able to diagnose up to 10% of fetal malformations with normal karyotype, 36, 37 whereas the application of WES, with or without CNV detection, has demonstrated a variable percentage of successful diagnosis in small cohorts of fetuses with ultrasound abnormalities. 38, 39 This study demonstrates that OneSeq was able to detect a wide range of genomic events, largely overcoming the limitations for CNVs detection by WES, mainly due to the uneven distribution of the reads, restricted to exons. We obtained high-level concordance between the 2 different pipelines we used, and between the size of the CNVs identified by the array and OneSeq approach (Table 1) .
Data analysis remains the major bottleneck of NGS in general and CNV detection particularly.
As for the minimal resolution for CNVs analysis in diagnostics, the panel we used, having a backbone resolution of 300 kb, is able to detect CNVs of 400 kb or larger, as recommended by the ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis. 40 This approach is a good compromise as long as WGS will be available in diagnostics, thanks to lower costs and proper interpretation algorithms. Software development and standardization as well as large prospective cohort studies are required to reinforce the benefit of every possible panel allowing combined detection of CNV, SNV and cnLOH.
